Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1984-06-07
1986-03-18
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514548, 514680, 514719, 514732, 568326, 568633, 568660, 568733, 560139, 560255, A61K 3122, C07C 4310, C07C 43205
Patent
active
045769648
ABSTRACT:
Tricyclic benzo fused compounds of the formula ##STR1## and pharmaceutically acceptable cationic and acid addition salts thereof, wherein n is zero, 1 or 2, and t is 1 or 2; M is CH or N, R.sub.1 is H or certain acyl groups; Q is CO.sub.2 R.sub.4, COR.sub.5, C(OR.sub.7)R.sub.5 R.sub.6, CN, CONR.sub.9 R.sub.10, CH.sub.2 NR.sub.9 R.sub.10, CH.sub.2 NHCOR.sub.11, CH.sub.2 NHSO.sub.2 R.sub.12, 5-tetrazolyl or when n is 1, Q and OR.sub.1 together form a lactone or certain reduced derivatives thereof; and Z is certain alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl groups, are valuable central nervous system active agents, methods for their use, pharmaceutical compositions containing them and certain intermediates therefor.
REFERENCES:
patent: 4188495 (1980-02-01), Althuis et al.
patent: 4476131 (1984-10-01), Eggler et al.
Eggler James F.
Johnson Michael R.
Melvin, Jr. Lawrence S.
Frost Albert E.
Helfin Bernard
Knuth Charles J.
Pfizer Inc.
Thomas Paul D.
LandOfFree
Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CN does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CN, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CN will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2306421